ABSTRACT. A new valved conduit was developed using a canine aortic valve. The bioprosthetic valve was fixed with glutaraldehyde and epoxy compound (Denacol-EX313/810). A vascular graft composed of ultra-fine polyester fiber (10 mm in diameter, 200 mm in length) was used. Four dogs underwent apico-aortic valved conduit (AAVC) implantation and aortic banding (bypass group, BG), while another 4 dogs underwent aortic banding without AAVC implantation (control group, CG). Cardiac catheterization and angiocardiography were performed for assessment of hemodynamics 2 weeks and 6 months after surgery. Left ventricular systolic pressure, left ventricular enddiastolic pressure and the left ventricular-aortic pressure gradient differed significantly (P<0.01) between the BG and CG dogs. Left ventricular angiocardiography showed patency of the valved conduit in all the BG dogs. Echocardiography was performed before and 2, 4 and 6 months after surgery, and showed that while pressure overload caused concentric myocardial hypertrophy in the CG dogs, the left ventricle dilated eccentrically in the BG dogs. Furthermore, relief of left ventricular pressure overload by AAVC was maintained. KEY WORDS: aortic banding, aortic stenosis, apico-aortic valved conduit, bioprosthetic valve.J. Vet. Med. Sci. 67(4): 357-362, 2005 Aortic stenosis (AS) is one of the most common congenital cardiac malformations observed in dogs, and the most frequently encountered cardiac disease, especially in large breeds. Of the three forms of AS, supravalvular, valvular and subvalvular, subvalvular aortic stenosis (SAS) is the most common form reported in dogs [2,4]. The clinical pathophysiology of all forms of AS, owing to left ventricular outflow tract obstruction (LVOTO), is an increase in left ventricular pressure overload and a pressure gradient across the obstruction. These factors cause left ventricular concentric hypertrophy and myocardial ischemia. The clinical signs of AS vary with the severity of the obstruction. While dogs with mild AS are asymptomatic, dogs with moderate to severe AS may have exercise intolerance, syncope and even sudden cardiac death occurring without premonitory signs.Medical therapy for AS, namely beta-adrenergic blockades or calcium channel antagonists have been empirically prescribed to improve diastolic dysfunction of the left ventricle and decrease myocardial oxygen demand [2,12]. However, their value is unproven. Since medical therapy is not effective for severely affected dogs, and they may often die suddenly, surgical relief of the LVOTO is recommended.Surgical treatment of AS in dogs includes closed transventricular dilation [15,18] and percutaneous transluminal balloon dilation [8,13]. However, these techniques may be inadequate for specific forms of AS, surgical dilation of lesions may produce regurgitation or increase preexistent regurgitation, and may introduce the possibility of recurrence after temporary relief of the condition.Thus, open resection of the obstructing lesions during cardiopulmonary bypass (CPB)...